"Purdue Pharma, under Sackler family control, aggressively marketed OxyContin as a safe, long-lasting pain reliever with low addiction risk. This marketing is widely blamed for igniting the devastating opioid epidemic in the U.S., which has led to hundreds of thousands of deaths."

Source: U.S. Dept. of Justice

"While Purdue Pharma has admitted wrongdoing, members of the Sackler family have consistently denied personal responsibility for the opioid crisis, arguing they acted legally and ethically."

Source: Congressional Hearings

"The central controversy of the Purdue Pharma bankruptcy is a proposed settlement that would grant broad legal immunity from future civil lawsuits to Sackler family members in exchange for a multi-billion dollar contribution. This has been fiercely contested by states and victims."

Source: Bankruptcy Court Filings

"Reports revealed that Sackler family members withdrew over $10 billion from Purdue Pharma in the years leading up to its bankruptcy, fueling accusations they were draining the company while aware of its mounting legal liabilities."

Source: The New York Times

"The family were once among the world's largest philanthropists, donating hundreds of millions to museums (like the Met, Louvre, Tate) and universities. Following the opioid crisis revelations, many institutions have removed the Sackler name from their buildings and refused further donations."

Source: Artforum

"Have been the target of high-profile protests by activist groups like P.A.I.N. (Prescription Addiction Intervention Now), led by artist Nan Goldin, demanding accountability and for institutions to reject Sackler funding."

Source: Documentary "All the Beauty and the Bloodshed"

"The U.S. Supreme Court temporarily blocked the Purdue Pharma bankruptcy settlement over concerns about the legality of granting broad legal immunity to the Sackler family members who had not personally filed for bankruptcy."

Source: SCOTUS Decisions